enow.com Web Search

  1. Ads

    related to: latest developments in schizophrenia treatment in atlanta

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    Cobenfy offers new hope for people with schizophrenia, providing an innovative treatment option that could change how this condition is managed, according to Jelena Kunovac, MD, a board-certified ...

  3. FDA approves new type of schizophrenia drug - AOL

    www.aol.com/news/fda-approves-type-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

  4. FDA Approves the First New Schizophrenia Drug in Decades - AOL

    www.aol.com/fda-approves-first-schizophrenia...

    N o new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

  5. Ulotaront - Wikipedia

    en.wikipedia.org/wiki/Ulotaront

    The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [18] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [19]

  6. Skyland Trail - Wikipedia

    en.wikipedia.org/wiki/Skyland_Trail

    Skyland Trail is a private, non-profit organization in Atlanta, Georgia offering treatment to adults ages 18 and older and adolescents ages 14 to 17 with mental illnesses. Skyland Trail specializes in treating adults and adolescents with bipolar disorder , schizophrenia , depression , and anxiety disorders. [ 1 ]

  7. Brilaroxazine - Wikipedia

    en.wikipedia.org/wiki/Brilaroxazine

    Brilaroxazine (developmental code name RP5063), also known as oxaripiprazole, [1] [2] is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of neuropsychiatric and inflammatory disorders. [3] [5] [6] [7] It has currently completed the first of two phase III clinical trials for ...

  1. Ads

    related to: latest developments in schizophrenia treatment in atlanta